ABBV dividend yield: 3.67%. MS dividend yield: 4.00%. AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug. MS is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MS shares.
AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.
MS is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MS shares.
ABBV currently offers a 3.67% yield (6.20/share/year) while MS offers 4.00% (2.00/share/year). MS provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in ABBV vs MS earn per year?
With $10,000 invested today: ABBV pays approximately $367/year. MS pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $1,154/year (ABBV) and $899/year (MS).
Does ABBV or MS pay monthly dividends?
ABBV pays quarterly dividends. MS pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this ABBV vs MS comparison by email
Save your analysis + get weekly dividend insights. Free forever.